Wpg Advisers, LLC Gilead Sciences, Inc. Transaction History
Wpg Advisers, LLC
- $107 Billion
- Q1 2025
A detailed history of Wpg Advisers, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Wpg Advisers, LLC holds 968 shares of GILD stock, worth $97,129. This represents 0.1% of its overall portfolio holdings.
Number of Shares
968
Previous 749
29.24%
Holding current value
$97,129
Previous $69.2 Million
56.77%
% of portfolio
0.1%
Previous 0.06%
Shares
2 transactions
Others Institutions Holding GILD
# of Institutions
2,272Shares Held
996MCall Options Held
9.63MPut Options Held
9.92M-
Black Rock Inc. New York, NY121MShares$12.1 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$11.8 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$5.97 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$5.48 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$5.37 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $126B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...